EUVIMEDEUVIMED entdecken
Übersichtsarbeit

AI and telemedicine in management of diabetes

Sava Petrov iD, Dean Donkov iD, Maria Orbetzova

Folia Medica · 2025

DOI: 10.3897/folmed.67.e153728 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Folia Medica, 2025. Verfasst von Sava Petrov und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical University of Plovdiv, Plovdiv, Bulgaria. Hauptthemen laut MEDLINE: Telemedicine, Artificial Intelligence, Diabetes Mellitus. Die Arbeit nennt 79 Literaturangaben. Gefördert von: National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review explores how two cutting-edge technologies—telemedicine and artificial intelligence (AI)—are reshaping diabetes care. Diabetes remains one of healthcare’s toughest challenges, demanding round-the-clock monitoring and treatments that adapt to each patient’s needs. During COVID-19, telemedicine proved its worth as a vital tool for maintaining patient care and improving health outcomes. Meanwhile, AI—through machine learning (ML) and deep learning (DL)—brings fresh capabilities for catching diabetes early, assessing patient risk, and spotting complications like eye and nerve damage before they become serious. We examined recent research on these technologies, particularly their roles in predicting who might develop diabetes, using Natural Language Processing (NLP) to decode messy patient records, and supporting doctors through clinical decision support systems (CDSS). Our findings reveal that telemedicine works—it helps patients control their blood sugar better and keeps them satisfied with their care. However, not everyone has equal access to technology, and some healthcare providers remain skeptical. AI diagnostic tools, especially for eye screening, now match human doctors in accuracy. Though merging these technologies could revolutionize personalized diabetes care, we first need to tackle real-world obstacles: ensuring fair access for all patients, protecting sensitive health data, and making different systems work together seamlessly.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TelemedicineArtificial IntelligenceDiabetes MellitusHumansCOVID-19SARS-CoV-2Deep LearningDecision Support Systems, ClinicalMachine LearningNatural Language Processing

Stichwörter der Autor:innen

AI CGM diabetes telemedecine

Autor:innen und Institutionen

  • Medical University of Plovdiv, Plovdiv, Bulgaria.
  • University of Telecommunications and Posts, Sofia, Bulgaria.
  • Medical Univeristy of Plovdiv, Plovdiv, Bulgaria.

ORCID-Profile: Sava Petrov, Dean Donkov

Förderung

  • National Institutes of Health

Zitieren

APA

Petrov, S., Donkov, D., & Orbetzova, M. (2025). AI and telemedicine in management of diabetes. Folia Medica. https://doi.org/10.3897/folmed.67.e153728

Vancouver

Petrov S, Donkov D, Orbetzova M. AI and telemedicine in management of diabetes. Folia Medica. 2025. doi:10.3897/folmed.67.e153728

BibTeX
@article{Petrov2025,
  author = {Petrov, Sava and Donkov, Dean and Orbetzova, Maria},
  title = {AI and telemedicine in management of diabetes},
  journal = {Folia Medica},
  year = {2025},
  doi = {10.3897/folmed.67.e153728}
}
Kostenlos starten →